A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers
Clinical trial NCT07300202 · COMPLETED
Trial details
- NCT number
- NCT07300202
- Sponsor
- Oriplantee Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2025-06-16
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.